Research progress in the treatment of minor stroke
10.3760/cma.j.cn114798-20241121-00898
- VernacularTitle:急性轻型卒中治疗的研究进展
- Author:
Lingming KONG
1
;
Xuelian DENG
;
Lin YIN
Author Information
1. 成都市第七人民医院神经内科，成都 610213
- Publication Type:Journal Article
- Keywords:
Stroke;
Antiplatelet therapy;
Endovascular treatment;
Anticoagulation therapy;
Intravenous thrombolysis
- From:
Chinese Journal of General Practitioners
2025;24(7):868-871
- CountryChina
- Language:Chinese
-
Abstract:
Minor stroke has a high incidence, accounting for up to 50% of acute ischemic stroke (AIS). The symptoms are typically mild at the initial onset, with significant concealment, and thus are easily overlooked by patients, leading to delayed medical intervention. However, minor stroke is associated with a high recurrence rate and susceptibility to early neurological deterioration (END), which may rapidly worsen the condition. This often results in missing the optimal treatment window and unfavorable prognoses. Currently, controversies persist regarding standardized treatment strategies for minor stroke, as inappropriate interventions could increase the risk of disability and mortality. This article reviews recent research advances in treatment plans for patients with a National Institutes of Health Stroke Scale (NIHSS) score ≤5, aiming to summarize the latest evidence and provide references for clinical practice.
